Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Wills Eye Hospital
Department of Neuro-Ophthalmology840 Walnut Street, Suite 930
Philadelphia, Pennsylvania, United States
Phone Web
Wills Eye Hospital, located in Philadelphia, Pennsylvania, is committed to excellence in patient care, vision research, and ophthalmic education. The Wills Eye Hospital was established in 1832 through a bequest of Quaker merchant James Wills to the City of Philadelphia. The Wills Eye Institute is governed by the Board of Directors of City Trusts. It is a non-profit specialty institution whose clinical expertise and sophistication of diagnostic and treatment procedures make it a worldwide referral center.
The Wills Eye Hospital has consistently been ranked as one of the best hospitals in the United States by U.S. News & World Report since the survey’s inception in 1990. Programs maintained by Wills Eye Institute are organized along the traditional divisions of patient care, education, and research activities.
Service Chief, Robert C. Sergott, MD, leads the renowned Neuro-Ophthalmology Department at Wills Eye Hospital with his team of fellow neuro-ophthalmologists, medical and administrative staff. The specialists diagnose and treat all disorders that affect the nerves and muscles in and around the eye and also treat ocular manifestations of glandular conditions, such as thyroid eye disease, (Graves’ eye disease) as well as autoimmune diseases, such as multiple sclerosis (MS), and Parkinson’s disease (PD). In addition to these conditions, the neuro-ophthalmologists at Wills Eye also treat optic neuropathy, myasthenia gravis, and the ocular disorders that may occur with brain tumors, AIDS and stroke.
myBinderRelated Content
-
Seattle Children’s Thyroid ProgramSeattle Children’s Thyroid Program is ...
-
Advances in the Pharmacological Treatment of Graves’ OrbitopathyGraves' orbitopathy has a deteriorating ...
-
Meta-Analysis of Methylprednisolone Pulse Therapy for Graves’ OphthalmopathyA meta-analysis was performed to evaluat...
-
American Association of Endocrine SurgeonsThe American Association of Endocrine Su...
-
Mount Sinai – Center for Thyroid and Parathyroid DiseasesAt Mount Sinai’s Center for Thyroid an...
-
Teprotumumab, an Insulin-Like Growth Factor-1 Receptor Antagonist Antibody, in the Treatment of Active Thyroid eye D...Thyroid eye disease is a disabling autoi...
-
Eric Hink, MDEric Hink is Associate Professor of opht...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Facebook
Google